Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

How Cells Tolerate DNA Damage – MDC Researchers Identify Start Signal for Cell Survival Program

18.11.2009
Cancer researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch have gained new insights into how cells react to DNA damage.

Dr. Michael Stilmann, Dr. Michael Hinz and Professor Claus Scheidereit have shown that the protein PARP-1, which detects DNA damage within seconds, activates the transcription factor NF-kappaB, a well-known regulator of gene expression. NF-kappaB triggers a survival program, which blocks programmed cell death.

The activation of NF-kappaB is thought to be one of the potential causes for tumor cell resistance to chemo and radiation therapy. (Molecular Cell, online, doi 10.1016/j.molcel.2009.09.032; Preview: doi 10.1016/j.molcel.2009.10.022)*.

The DNA of each human cell is damaged many times every day. DNA lesions can be caused by ultraviolet radiation, errors in cell division, DNA-damaging chemicals or intracellular metabolic products. Damaged chromosomal DNA can ultimately be the cause for serious diseases, such as cancer.

However, cells have developed complex systems that recognize DNA lesions within seconds and ensure that the damage will be repaired. In case of massive DNA damage, the affected cell can be destroyed by initiating apoptosis (programmed cell death).

Apoptosis is a cellular program which drives defective cells to commit suicide, thus protecting the organism as a whole. Another regulator of gene expression, the transcription factor p53 – also known as the “guardian of the genome” – has a key function in the activation of programmed cell death. But p53 is not always successful in switching on the protective program.

NF-kappaB opposes the function of p53, in turn activating a survival program which protects the damaged cells from destruction. The activation of this program by NF-kappaB is considered to be one of the possible causes for resistance of tumor cells to chemo or radiation therapy.

The transcription factor NF-kappaB not only regulates cell survival programs, it also plays an important role in the immune system and in inflammatory processes. NF-kappaB can be switched on by a number of extracellular and intracellular stimuli.

Such stimulation alters the activity of protein-regulated signaling pathways, which ultimately activate NF-kappaB. The process of signal transduction initiated by external physiological stimuli has been well characterized in recent years.

However, it was not understood how NF-kappaB is switched on by DNA damage. MDC researchers have now succeeded in illuminating this particular signaling pathway.

Professor Scheidereit and his colleagues Dr. Stilmann and Dr. Hinz discovered that the DNA damage detector PARP-1 plays a key role in the activation of NF-kappaB. PARP-1 recognizes sites of DNA damage within seconds and then attracts several proteins, which are important for this signaling pathway, to form a complex in the cell nucleus.

Due to subsequent chemical changes in the complexed proteins, signals are generated, which then trigger NF-kappaB activation. “We have thus identified the start signal for NF-kappaB activation”, Dr. Stilmann and Dr. Hinz explained.

Now the researchers want to investigate further components of this signal transmission cascade and their interaction. “For medical research it is of enormous significance to understand these signaling pathways. This is based on the hope to identify targets for the development of drugs, which allow to switch off the survival factor NF-kappaB in cancer diseases in a context-specific manner.”

Already now, clinical trials are in progress worldwide with various, not yet approved substances, which target and inhibit PARP-1 and which have gained much attention from the scientific community. In the context of these studies, experts consider the work of the MDC researchers to be of special significance.

Professor Scheidereit and his collaborators have been working for many years on NF-kappaB. Some years ago they were able to show that NF-kappaB plays a key role in tumor cell survival in Hodgkin’s lymphoma, a common lymph gland cancer.

*A nuclear Poly(ADP-ribose)-dependent signalosome confers DNA damage induced IκB kinase activation

Michael Stilmann1,2*, Michael Hinz1*, Seda Çöl Arslan1,3, Anja Zimmer1, Valérie Schreiber4 and Claus Scheidereit1

1Max Delbrück Center for Molecular Medicine, Robert-Rössle-Strasse 10, 13125 Berlin, Germany; 2Free University, Faculty of Biology, Chemistry and Pharmacy, Takustr. 3, 14195 Berlin; 3Humboldt University, Institute of Biology, Chausseestrasse 117, 10115 Berlin; 4Université Strasbourg 1, Institut Gilbert Laustriat, CNRS - UMR 7175, Département Intégrité du Génome, ESBS, Bld Sébastien Brant, BP 10413, Illkirch Cedex, France

* These authors contributed equally to this work

Barbara Bachtler
Press and Public Affairs
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Straße 10; 13125 Berlin; Germany
Phone: +49 (0) 30 94 06 - 38 96
Fax: +49 (0) 30 94 06 - 38 33
e-mail: presse@mdc-berlin.de
Further information:
Stephen P. Jackson, Jiri Bartek, The DNA-damage response in human biology and disease, Nature Vol. 461, October 22, 2009

Peter C. Fong et al., Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers ; New England Journal of Medicine, Vol. 361, Nr. 2, pp. 123-134, July 9, 2009

Barbara Bachtler | EurekAlert!
Further information:
http://www.mdc-berlin.de/
http://www.clinicaltrials.gov/ct2/results?term=PARP+inhibitor

More articles from Life Sciences:

nachricht Multi-institutional collaboration uncovers how molecular machines assemble
02.12.2016 | Salk Institute

nachricht Fertilized egg cells trigger and monitor loss of sperm’s epigenetic memory
02.12.2016 | IMBA - Institut für Molekulare Biotechnologie der Österreichischen Akademie der Wissenschaften GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

Im Focus: Fraunhofer ISE Develops Highly Compact, High Frequency DC/DC Converter for Aviation

The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.

Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

UTSA study describes new minimally invasive device to treat cancer and other illnesses

02.12.2016 | Medical Engineering

Plasma-zapping process could yield trans fat-free soybean oil product

02.12.2016 | Agricultural and Forestry Science

What do Netflix, Google and planetary systems have in common?

02.12.2016 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>